NEW YORK (GenomeWeb News) – Metabolon has raised $5.3 million from a Series C funding round, the firm said today.

The Research Triangle Park, NC-based metabolomics services company said that it anticipates raising a total of $11 million in the round. It closed the first $5.3 million last week, and it expects to receive the rest of the funding within the next 60 to 90 days.

Metabolon CEO John Ryals said that the funding will enable the firm to launch its diagnostics business with products for prostate cancer and insulin resistance.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.